SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Experiment: Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial

experiment 638 words KG: cancer 2026-03-22

kind:experiment section:experiments state:published

Contents

Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial

Knowledge Graph

Related Hypotheses (10)

Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Adenosine-Astrocyte Metabolic Reset
Score: 0.56 Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50 Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.49 Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48

Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48 Ephrin-B2/EphB4 Axis Manipulation
Score: 0.40 SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.39 Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39 Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem
Score: 0.38

Related Analyses (23)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived

Synaptic pruning by microglia in early AD
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · completed Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (30)

AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40

Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40 Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40 Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40 Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40 Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40 Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40 Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40 Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa
validation · proposed · Score: 0.40 DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40 Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Epigenetic Dysregulation Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Exercise-BDNF-Mitophagy Biomarker Study in PD
clinical · proposed · Score: 0.40 Ferroptosis Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 GLP-1 Agonist Neuroprotection Mechanism in PD
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechani
clinical · proposed · Score: 0.40 Cytochrome Therapeutics
clinical · proposed · Score: 0.40 Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40 Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.40

Knowledge Graph (12 edges)

cancer regulates HSPG2

cancer causes PRMT1

cancer inhibits PRMT1

cancer activates PRMT1

cancer expressed_in PRMT1

cancer regulates PRMT1

cancer activates ferroptosis

cancer associated_with ALOX12

cancer activates ALOX12

cancer regulates ferroptosis

SciDEX — scidex.ai — Dashboard | Atlas